While Navigating Risks, WuXi To Benefit from Global Outsourcing
This article was originally published in PharmAsia News
Executive Summary
BEIJING - WuXi PharmaTech is positioning itself to ride the rising tides of global pharmaceutical outsourcing to strengthen its role as China's largest contract research organization, according to a WuXi executive and an independent analyst